{"disease":{"id":"nash-nonalcoholic-steatohepatitis","name":"nash nonalcoholic steatohepatitis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04442334","title":"The European NAFLD Registry","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Newcastle University","has_results":false},{"nct_id":"NCT04371042","title":"PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT03726827","title":"A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk Populations","phase":"","overall_status":"COMPLETED","enrollment_count":1006,"lead_sponsor_name":"Fatty liver Foundation","has_results":false},{"nct_id":"NCT04849728","title":"A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Inventiva Pharma","has_results":false},{"nct_id":"NCT03289897","title":"Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan","phase":"NA","overall_status":"COMPLETED","enrollment_count":801,"lead_sponsor_name":"Perspectum","has_results":false},{"nct_id":"NCT04841057","title":"Biometabolic Outcomes After Weight Loss Surgery: An Individualized Approach","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":750,"lead_sponsor_name":"University of Missouri-Columbia","has_results":false},{"nct_id":"NCT04653103","title":"NASH in Subjects With Different Classes of Obesity","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Catholic University of the Sacred Heart","has_results":false},{"nct_id":"NCT05479721","title":"LITMUS Imaging Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":450,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT05023044","title":"Nonalcoholic Fatty Liver Disease in HIV Database","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT04365868","title":"Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":357,"lead_sponsor_name":"Galectin Therapeutics Inc.","has_results":false},{"nct_id":"NCT03439189","title":"Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14","phase":"","overall_status":"COMPLETED","enrollment_count":343,"lead_sponsor_name":"Meridian Bioscience, Inc.","has_results":true},{"nct_id":"NCT03858920","title":"The Liver in the World Trade Center Health Program General Responder Cohort and Controls","phase":"","overall_status":"COMPLETED","enrollment_count":340,"lead_sponsor_name":"Icahn School of Medicine at Mount Sinai","has_results":false},{"nct_id":"NCT05499949","title":"The Franciscus Obesity NASH Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Franciscus Gasthuis","has_results":false},{"nct_id":"NCT04173065","title":"A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":248,"lead_sponsor_name":"Viking Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04054310","title":"Non-Invasive Quantification of Liver Health in NASH (N-QUAN)","phase":"NA","overall_status":"RECRUITING","enrollment_count":225,"lead_sponsor_name":"Perspectum","has_results":false},{"nct_id":"NCT04561895","title":"Adipokine Genetic Variations in predictingNAFLD Progression to NASH in Egyptian Patients","phase":"","overall_status":"COMPLETED","enrollment_count":224,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT04929483","title":"Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":222,"lead_sponsor_name":"89bio, Inc.","has_results":true},{"nct_id":"NCT04505436","title":"Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":215,"lead_sponsor_name":"Hanmi Pharmaceutical Company Limited","has_results":false},{"nct_id":"NCT04773964","title":"Study to Evaluate MET642 in Patients With NASH","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":215,"lead_sponsor_name":"Metacrine, Inc.","has_results":false},{"nct_id":"NCT03551522","title":"A Study to Evaluate Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":181,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT03534141","title":"Mild Hypothermia and Acute Kidney Injury in Liver Transplantation","phase":"NA","overall_status":"TERMINATED","enrollment_count":175,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT03912532","title":"Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":171,"lead_sponsor_name":"NGM Biopharmaceuticals, Inc","has_results":true},{"nct_id":"NCT05415722","title":"DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":162,"lead_sponsor_name":"Terns, Inc.","has_results":true},{"nct_id":"NCT04616664","title":"Diagnostic Accuracy of the \"LLIFT\", a Novel Non-invasive Biomarker for the Diagnosis of Non Alcoholic Fatty Liver (NAFL) and SteatoHepatitis (NASH) in a Population With High Risk of Metabolic Syndrome\"","phase":"","overall_status":"COMPLETED","enrollment_count":158,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT04677101","title":"Liquid Biopsy for NASH and Liver Fibrosis","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Catholic University of the Sacred Heart","has_results":false},{"nct_id":"NCT04591106","title":"Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE","phase":"","overall_status":"COMPLETED","enrollment_count":135,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT03753308","title":"Mechanism of DCs Dysfunction in Chronic HBV Infection","phase":"","overall_status":"UNKNOWN","enrollment_count":132,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT06623084","title":"Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":132,"lead_sponsor_name":"Stefania Basili","has_results":false},{"nct_id":"NCT04767529","title":"A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"Akero Therapeutics, Inc","has_results":true},{"nct_id":"NCT03611101","title":"Companion Protocol for ¹³C-Methacetin Breath Tests in BMS: NCT03486899, NCT03486912 Referenced Trials","phase":"","overall_status":"COMPLETED","enrollment_count":124,"lead_sponsor_name":"Meridian Bioscience, Inc.","has_results":true},{"nct_id":"NCT04976283","title":"Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":123,"lead_sponsor_name":"Getz Pharma","has_results":false},{"nct_id":"NCT04321343","title":"Study of PXL065 in Patients With Nonalcoholic Steatohepatitis (NASH)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":117,"lead_sponsor_name":"Poxel SA","has_results":true},{"nct_id":"NCT04697810","title":"Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":114,"lead_sponsor_name":"Can-Fite BioPharma","has_results":false},{"nct_id":"NCT03976401","title":"A Study of Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Akero Therapeutics, Inc","has_results":true},{"nct_id":"NCT06342947","title":"ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Aligos Therapeutics","has_results":false},{"nct_id":"NCT04328077","title":"LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"Terns, Inc.","has_results":true},{"nct_id":"NCT04653311","title":"Evaluation of an Endoscopic Sutured Gastroplasty in Patients With NonAlcoholic Steatohepatitis (NASH) and Fibrosis.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Erasme University Hospital","has_results":false},{"nct_id":"NCT05090111","title":"A Study of ALG-055009 in Healthy Volunteers and Subjects With Hyperlipidemia","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":98,"lead_sponsor_name":"Aligos Therapeutics","has_results":false},{"nct_id":"NCT03648554","title":"Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":93,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT03868566","title":"An Open-Label Study to Assess the Hepatic Protection Effect of SNP-612, in Patients With NAFLD","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":90,"lead_sponsor_name":"Sinew Pharma Inc.","has_results":false},{"nct_id":"NCT04643795","title":"Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":87,"lead_sponsor_name":"Madrigal Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT03897218","title":"Dietary Modulation of Intestinal Microbiota as Trigger of Liver Health: Role of Bile Acids - \"A Diet for Liver Health\"","phase":"NA","overall_status":"COMPLETED","enrollment_count":84,"lead_sponsor_name":"RWTH Aachen University","has_results":false},{"nct_id":"NCT04559126","title":"A Study of EDP-297 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"Enanta Pharmaceuticals, Inc","has_results":false},{"nct_id":"NCT04874233","title":"Phase 2a Study of HU6 in Subjects With Elevated Liver Fat and High BMI Volunteers","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Rivus Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04146805","title":"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Blade Therapeutics","has_results":false},{"nct_id":"NCT03468556","title":"A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic Steatohepatitis","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":80,"lead_sponsor_name":"Sinew Pharma Inc.","has_results":false},{"nct_id":"NCT02581085","title":"Tocotrienol Against the Progression of End Stage Liver Disease","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":70,"lead_sponsor_name":"Chandan Sen","has_results":false},{"nct_id":"NCT04463017","title":"Ascending Dose Study of HU6 in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Rivus Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT04781933","title":"Interest in \"Combo\" (a Combination of Dietary Supplements Including Probiotics) in NASH Improvement","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Mativa-Tech SA","has_results":false},{"nct_id":"NCT03132662","title":"Omega-3 vs Very Low Calorie Diet for Liver Size Reduction","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"McMaster University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}